(19)
(11) EP 3 728 311 A1

(12)

(43) Date of publication:
28.10.2020 Bulletin 2020/44

(21) Application number: 18898849.7

(22) Date of filing: 20.12.2018
(51) International Patent Classification (IPC): 
C07K 16/10(2006.01)
C07K 16/28(2006.01)
C07K 16/18(2006.01)
(86) International application number:
PCT/US2018/066643
(87) International publication number:
WO 2019/135921 (11.07.2019 Gazette 2019/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.12.2017 US 201715850832

(71) Applicant: Aaron Diamond Aids Research Center
New York, NY 10016 (US)

(72) Inventors:
  • HO, David D.
    Chappaqua, NY 10514 (US)
  • HUANG, Yaoxing
    Brooklyn, NY 11204 (US)
  • YU, Jian
    New Providence, NJ 07974 (US)

(74) Representative: Grund, Martin et al
Grund Intellectual Property Group Patentanwalt und Solicitor PartG mbB Postfach 44 05 16
80754 München
80754 München (DE)

   


(54) BISPECIFIC HIV-1-NEUTRALIZING ANTIBODIES